Search Orphan Drug Designations and Approvals
-
Generic Name: | nevanimibe HCL |
---|---|
Date Designated: | 08/17/2017 |
Orphan Designation: | Treatment of congenital adrenal hyperplasia |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 01/04/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Millendo Therapeutics, Inc. 301 North Main Street Suite 100 Ann Arbor, Michigan 48104 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-